Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial

Published:2022-01 Issue:1 Volume:10 Page:35-46
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Rosenkranz Stephan,Feldman Jeremy,McLaughlin Vallerie V,Rischard Franz,Lange Tobias J,White R James,Peacock Andrew J,Gerhardt Felix,Ebrahimi Ramin,Brooks Gabriel,Satler Carol,Frantz Robert P

Funder

Gilead Sciences Inc

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference32 articles.

1. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension;Kylhammar;Eur Heart J,2018

2. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model;Hoeper;Eur Respir J,2017

3. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension;Boucly;Eur Respir J,2017

4. The molecular targets of approved treatments for pulmonary arterial hypertension;Humbert;Thorax,2016

5. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives;Humbert;Eur Respir J,2019

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain;Frontiers in Immunology;2024-08-02

3. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

4. Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging;Communications Biology;2024-06-05

5. Inhibiting the Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Cascade in Cancer and the Heart: for Better or Worse, in Sickness and Health?;International Journal of Drug Discovery and Pharmacology;2024-05-23